GLP1 Europe › Fake pens
How to spot a fake GLP-1 pen
Short answer
Fake GLP-1 pens are real, documented, and have put people in hospital. The 2023 wave of fake Ozempic contained insulin instead of semaglutide, which caused seizures and comas.
There are specific checks: known counterfeit batch numbers, physical tells the regulators published, and one structural fact that matters more than any of them. Every legitimate prescription pack in Europe carries a scannable unique barcode that a pharmacy verifies and kills at the counter. Anything sold outside a pharmacy has left that system entirely.
What has actually happened
This is not a theoretical risk. The documented record, briefly:
October 2023, the fake Ozempic wave. Pens falsely labelled as Ozempic 1 mg appeared at wholesalers in Austria, Germany and the UK, with batch numbers and barcodes copied from genuine packs. In Austria, several people were hospitalised with hypoglycaemia and seizures: the pens contained insulin, not semaglutide. The UK regulator seized 369 suspected fake pens that year and reported a small number of patients in hypoglycaemic shock, some in comas. The World Health Organization issued a global alert in June 2024 naming specific falsified batches.
February 2026, fake Mounjaro in a legal pharmacy. Falsified Mounjaro KwikPen 15 mg pens, batch D873576, were supplied through one UK online pharmacy. The dose knob detached during use. This one matters because it crossed into the legitimate chain, which is rare, and it was caught and recalled precisely because that chain has a verification system.
2025 and 2026, the unlicensed pen factories. In October 2025 the UK regulator raided the first illicit weight-loss injection production line found in the country, seizing more than 2,000 unlicensed retatrutide and tirzepatide pens and tens of thousands of empty pens waiting to be filled. In May 2026 it made its largest seizure yet, around 12,000 doses. Empty pens plus a filling line means products dressed as branded medicines, with whatever the operators put inside.
July 2026, the Netherlands. Two patients ended up in comas after "semaglutide" bought online turned out to contain insulin. The same trick as 2023, still working.
The checks, in order of strength
1. Where you bought it decides almost everything
Since 2019, every prescription medicine pack in the EU carries two legally required safety features: a unique identifier in a 2D barcode, and an anti-tamper device. Pharmacies scan each pack against a Europe-wide database and decommission the code when they hand it over. The 2023 fakes looked perfect, but their serial numbers showed as inactive when scanned, which is how wholesalers caught them.
Follow the logic: a pack from a licensed pharmacy has been verified against that database moments before reaching you. A pen from Instagram, Telegram, a "research" site or an unregistered online shop has left the system, and its barcode, however real it looks, has been checked by nobody. There is no home version of that scan. This is why source beats every visual check below.
2. Check the batch and serial numbers
Known falsified Ozempic batches published by WHO include LP6F832, NAR0074 with serial 430834149057, and MP5E511. The falsified UK Mounjaro batch was D873576. Counterfeiters also combine a genuine lot number with a serial that does not belong to it, which is why manufacturers publish both in their alerts.
For tirzepatide products, Eli Lilly runs an authenticity checker at scan.lilly.com. Lilly has also stated in writing that it supplies tirzepatide to no compounders, no online retailers and no resellers, which means a grey-market vial labelled tirzepatide is, by the manufacturer's own definition, not a Lilly product regardless of what its label claims.
3. The physical tells from the Austrian cases
The Austrian regulator published exactly how the insulin-filled fakes differed from genuine Ozempic pens, and the list is usefully specific:
- The dose scale extended out of the pen when the dose was dialled. A genuine Ozempic pen's scale never extends.
- The pen body was a noticeably darker blue.
- The safety window was fully transparent rather than as specified.
- The included needles were the wrong specification, 31 gauge rather than 32.
- Label quality and spelling are recurring weaknesses across all counterfeit cases, per WHO.
4. Price is a check too
Interpol's 2026 operation found illicit GLP-1 products from Asia offered from ten US dollars, some containing sibutramine, a withdrawn appetite suppressant banned in the EU since 2010. A price dramatically below the pharmacy price is not a bargain signal, it is a counterfeiting signal, because nobody undercuts a monopoly manufacturer by ninety percent while selling the real molecule.
What is inside fakes, when tested
| Case | Claimed | Actually contained |
|---|---|---|
| Austria 2023, hospitalisations | Semaglutide (Ozempic) | Insulin |
| Netherlands 2026, two comas | Semaglutide | Insulin |
| Interpol 2026 seizures | GLP-1 products | Sibutramine in some |
| Lilly testing of knock-offs | Tirzepatide | Bacteria, high impurities, wrong molecule, in one case only a sugar alcohol |
| Grey-market vials, JMIR study | 99% pure semaglutide | 7.7 to 14.4% purity, endotoxin in every sample |
If you suspect a fake
Stop using it and keep everything: pen, packaging, leaflet. Report it to your national medicines agency, in the UK through the Yellow Card scheme, and to the manufacturer, both of whom investigate these reports. If it came from a pharmacy, tell the pharmacy too, because a falsified pack inside the legal chain triggers a recall that protects other people.
Common questions
- Can I verify a pen's barcode myself?
No. The verification system is available to pharmacies and wholesalers, not consumers. That is not a gap you can work around, it is the reason buying inside the pharmacy chain matters: the check has already been done for you at the counter.
- Do fake pens look obviously fake?
No. The 2023 fakes carried copied batch numbers and barcodes good enough to pass visual inspection at wholesalers. The tells above helped, but the packs were caught by database checks, not by looks.
- Are "retatrutide pens" a real product?
No. Retatrutide has never been manufactured as an authorised medicine anywhere, so there is no genuine retatrutide pen to counterfeit. Every retatrutide pen, by definition, comes from an unlicensed production line like the ones raided in the UK. Its actual status is here.
Sources
- EMA, alert on falsified Ozempic pens, 18 October 2023.
- BASG (Austria), update on falsified Ozempic including the physical differences, 31 October 2023.
- MHRA, "MHRA warns of unsafe fake weight loss pens", 26 October 2023.
- WHO, Medical Product Alert N°2/2024, falsified Ozempic, 19 June 2024, including batch numbers.
- MHRA Drug Safety Update, falsified Mounjaro KwikPen 15 mg, batch D873576, 24 February 2026.
- MHRA, raid on illicit weight-loss medicine production, October 2025; largest-ever seizure with two arrests, 28 May 2026.
- Pharmaceutisch Weekblad, two patients in coma after falsified semaglutide, July 2026.
- Eli Lilly, open letter on counterfeit and compounded tirzepatide, 20 June 2024, and scan.lilly.com.
- Novo Nordisk UK, counterfeit product guidance.
- Interpol, Operation Pangea XVIII results, March 2026.
- Commission Delegated Regulation (EU) 2016/161, safety features for medicinal products.
- Ashraf AR, et al. Journal of Medical Internet Research, 2024;26:e65440.
This page describes documented counterfeiting cases and published verification guidance. It is not medical advice, and it is not a guide to buying anything. If you may have used a falsified medicine and feel unwell, seek medical help now and tell them what you suspect.